Skip to main content

Case 12: Huntington’s Disease with Atypical Onset

  • Chapter
  • First Online:
Clinical Nuclear Medicine in Neurology

Abstract

Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by an expanded CAG repeat in the HTT gene. Genetic testing represents current routine standard in the diagnostic pathway of HD. However patients might be submitted to [18F]FDG PET to support the differential diagnosis of cognitive impairment or behavioral disturbances and might guide the subsequent work-up of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Ellis N, Tee A, McAllister B, Massey T, McLauchlan D, Stone T, et al. Genetic risk underlying psychiatric and cognitive symptoms in Huntington’s disease. Biol Psychiatry. 2020;87:857–65.

    Article  CAS  Google Scholar 

  • Gamez J, Lorenzo-Bosquet C, Cuberas-Borrós G, Carmona F, Badía M, Castilló J, Badía M, de Fabregues O, Hernández-Vara J, Castell-Conesa J. Progressive presynaptic dopaminergic deterioration in Huntington disease: a [123I]-FP-CIT SPECT two-year follow-up study. Clin Nucl Med. 2014;39(3):e227–8. https://doi.org/10.1097/RLU.0b013e31828162cd. PMID: 23531734

    Article  PubMed  Google Scholar 

  • Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. Identification of genetic factors that modify clinical onset of Huntington’s disease. Cell. 2015;162:516–26.

    Article  Google Scholar 

  • Gusella JF, MacDonald ME, Lee JM. Genetic modifiers of Huntington’s disease. Mov Disord. 2014;29:1359–65.

    Article  CAS  Google Scholar 

  • Hwang WJ, Yao WJ. SPECT study of the nigrostriatal dopaminergic system in Huntington’s disease. J Neuroimaging. 2013;23(2):192–6. https://doi.org/10.1111/j.1552-6569.2011.00671.x. PMID: 22211920

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia Morbelli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Morbelli, S., Ferrarazzo, G. (2022). Case 12: Huntington’s Disease with Atypical Onset. In: Varrone, A., Morbelli, S., Garibotto, V. (eds) Clinical Nuclear Medicine in Neurology. Springer, Cham. https://doi.org/10.1007/978-3-030-83598-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-83598-9_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-83597-2

  • Online ISBN: 978-3-030-83598-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics